|
6BSB
Crystal structure of the Mucin-1 SEA domain, L1105M mutant, Selenium-derivative
Deposited 2017-12-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1041–1097(57 aa)
Fragment:SEA domain, N-terminal
Chain B
1098–1152(55 aa)
Fragment:SEA domain, C-terminal
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;Native crystals (see related entry) were used as seeds in a drop of 1:1 mix of the SeMet-derivative (9 mg/ml in 10 mM Tris-Cl, pH 7.4) and reservoir solution (0.1 M sodium acetate trihydrate pH 4.6, 1.75 M sodium chloride, 0.2 M ammonium sulfate).
|
Resolution 1.60 Å
R-free 0.222
|
|
6BSC
Crystal structure of the Mucin-1 SEA domain
Deposited 2017-12-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1041–1097(57 aa)
Fragment:SEA domain, N-terminal
Chain B
1098–1152(55 aa)
Fragment:SEA domain, C-terminal
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;Drop was a 1:1 mix of protein (10 mg/ml in 10 mM Tris-Cl, pH 7.4) and reservoir solution (0.1 M sodium acetate trihydrate pH 4.6, 2.0 M sodium chloride)
|
Resolution 1.30 Å
R-free 0.184
|
|
6FZQ
Crystal structure of scFv-SM3 in complex with compound 3
Deposited 2018-03-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
141–146(6 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 10
EEN 2-deoxy-2-[(difluoroacetyl)amino]-alpha-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350
disodium hydrogen phosphate
|
Resolution 1.70 Å
R-free 0.225
|
|
6FZR
Crystal structure of scFv-SM3 in complex with compound 2
Deposited 2018-03-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
141–146(6 aa)
Fragment:UNP residues 141-146
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 8
EEQ 2-deoxy-2-[(fluoroacetyl)amino]-alpha-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350
disodium hydrogen phosphate
|
Resolution 1.80 Å
R-free 0.232
|
|
6TGG
scFv-1SM3 in complex with glycopeptide containing an sp2-imino sugar
Deposited 2019-11-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
141–146(6 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 4
N8W ~{N}-[(6~{S},7~{R},8~{S},8~{a}~{R})-7,8-bis(oxidanyl)-3-oxidanylidene-1,5,6,7,8,8~{a}-hexahydro-[1,3]oxazolo[3,4-a]pyridin-6-yl]ethanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350
disodium hydrogen phosphate
|
Resolution 2.00 Å
R-free 0.237
|
|
7Q4I
Crystal structure of DmC1GalT1 in complex with UDP-Mn2+ and the APD-TGalNAc-RP
Deposited 2021-10-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain F
141–146(6 aa)
Chain G
141–146(6 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
UDP URIDINE-5'-DIPHOSPHATE × 2
EDO 1,2-ETHANEDIOL × 3
MN MANGANESE (II) ION × 2
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;potassium thiocyanate, Polyethylene glycol monomethyl ether 2,000
|
Resolution 2.40 Å
R-free 0.235
|
|
7V4W
Crystal structure of Antibody 16A in complex with MUC1 peptide
Deposited 2021-08-15
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
145–157(13 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289 K;Di-sodium hydrogen phosphate 0.2M, PEG 3350 20%
|
Resolution 2.10 Å
R-free 0.233
|
|
7V64
Crystal structure of Antibody 16A in complex with MUC1 Glycopeptide(GlycoT)
Deposited 2021-08-19
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;289 K;1.0 M Lithium chloride, 0.1 M Tris pH 8.5, 20% PEG 6000
|
Resolution 1.56 Å
R-free 0.203
|
|
7V7K
Crystal structure of Antibody 16A in complex with MUC1 Glycopeptide(GlycoST)
Deposited 2021-08-21
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;289 K;1.0 M Lithium chloride, 0.1 M Tris pH 8.5, 20%(w/v) PEG 6000
|
Resolution 2.20 Å
R-free 0.251
|
|
7V8Q
Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT)
Deposited 2021-08-23
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;289 K;Crystal screen D4=JCSG F7, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 20% v/v 2-Propanol, 20% w/v Polyethylene glycol 4000
|
Resolution 3.20 Å
R-free 0.244
|
|
7V8Q
Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT)
Deposited 2021-08-23
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain H
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;289 K;Crystal screen D4=JCSG F7, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 20% v/v 2-Propanol, 20% w/v Polyethylene glycol 4000
|
Resolution 3.20 Å
R-free 0.244
|
|
7V8Q
Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT)
Deposited 2021-08-23
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;289 K;Crystal screen D4=JCSG F7, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 20% v/v 2-Propanol, 20% w/v Polyethylene glycol 4000
|
Resolution 3.20 Å
R-free 0.244
|
|
7VAC
Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST)
Deposited 2021-08-28
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 3.50 Å
R-free 0.219
|
|
7VAC
Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST)
Deposited 2021-08-28
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain H
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 3.50 Å
R-free 0.219
|
|
7VAC
Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST)
Deposited 2021-08-28
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 3.50 Å
R-free 0.219
|
|
7VAZ
Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS)
Deposited 2021-08-30
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
145–157(13 aa)
|
Not recorded
|
NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 2.73 Å
R-free 0.264
|
|
7VAZ
Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS)
Deposited 2021-08-30
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
145–157(13 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 2.73 Å
R-free 0.264
|
|
7VAZ
Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS)
Deposited 2021-08-30
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
145–157(13 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 2.73 Å
R-free 0.264
|
|
8AXH
Crystal structure of a MUC1-like glycopeptide containing the unnatural L-4-hydroxynorvaline in complex with scFv-SM3
Deposited 2022-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
141–146(6 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 6
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350
disodium hydrogen phosphate
|
Resolution 1.85 Å
R-free 0.206
|
|
8P6I
Crystal structure of the 139H2 Fab fragment bound to Muc1 peptide epitope
Deposited 2023-05-26
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
141–149(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;293 K;0.2M NaCl
20%w/v PEG 8K
0.1M Na Phos Cit pH 4.2
|
Resolution 2.50 Å
R-free 0.254
|
|
8P6I
Crystal structure of the 139H2 Fab fragment bound to Muc1 peptide epitope
Deposited 2023-05-26
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain a
141–149(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;293 K;0.2M NaCl
20%w/v PEG 8K
0.1M Na Phos Cit pH 4.2
|
Resolution 2.50 Å
R-free 0.254
|
|
8S6K
Crystal structure of ScFv-G2D11 complexed to a bis-Tn glycopeptide
Deposited 2024-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain M
127–133(7 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 7
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;291 K;lithium chloride
Tris
PEG 8000
|
Resolution 1.75 Å
R-free 0.221
|
|
8S6K
Crystal structure of ScFv-G2D11 complexed to a bis-Tn glycopeptide
Deposited 2024-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain N
127–133(7 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 5
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;291 K;lithium chloride
Tris
PEG 8000
|
Resolution 1.75 Å
R-free 0.221
|
|
8S6T
Crystal structure of Fab-3F1 complexed to a bis-STn glycopeptide
Deposited 2024-02-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
126–138(13 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;291 K;Magnesium chloride hexahydrate
calcium chloride dihydrate
NDSB
sodium HEPES
MOPS
ethylene glycol
PEG 8000
|
Resolution 1.85 Å
R-free 0.267
|
|
8S6V
Crystal structure of Fab-2D9 chimera complexed to a bis-Tn glycopeptide
Deposited 2024-02-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain M
127–135(9 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 4
SO4 SULFATE ION × 2
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291 K;lithium sulfate
Bis-Tris
PEG 3350
|
Resolution 1.95 Å
R-free 0.244
|
|
8S6V
Crystal structure of Fab-2D9 chimera complexed to a bis-Tn glycopeptide
Deposited 2024-02-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain N
127–135(9 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 7
SO4 SULFATE ION × 3
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291 K;lithium sulfate
Bis-Tris
PEG 3350
|
Resolution 1.95 Å
R-free 0.244
|